Use of win time for ordered composite endpoints in clinical trials
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | James F. Troendle, Eric S. Leifer, Song Yang, Neal Jeffries, Dong‐Yun Kim, Jungnam Joo, Christopher M. O'Connor |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
por: Wenhao Cao, et al.
Publicado: (2024)
por: Wenhao Cao, et al.
Publicado: (2024)
Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
por: Matthias Kormaksson, et al.
Publicado: (2024)
por: Matthias Kormaksson, et al.
Publicado: (2024)
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
por: Luana Boumendil, et al.
Publicado: (2024)
por: Luana Boumendil, et al.
Publicado: (2024)
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
por: Edward L. Korn, et al.
Publicado: (2024)
por: Edward L. Korn, et al.
Publicado: (2024)
Assurance methods for designing a clinical trial with a delayed treatment effect
por: James A. Salsbury, et al.
Publicado: (2024)
por: James A. Salsbury, et al.
Publicado: (2024)
Correction to “Using principal stratification in analysis of clinical trials”
por: Ilya Lipkovich, et al.
Publicado: (2024)
por: Ilya Lipkovich, et al.
Publicado: (2024)
Robust analysis of stepped wedge trials using composite likelihood models
por: Emily C. Voldal, et al.
Publicado: (2024)
por: Emily C. Voldal, et al.
Publicado: (2024)
Confidence distributions for treatment effects in clinical trials: Posteriors without priors
por: Ian C. Marschner
Publicado: (2024)
por: Ian C. Marschner
Publicado: (2024)
Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
por: Shuxi Zeng, et al.
Publicado: (2024)
por: Shuxi Zeng, et al.
Publicado: (2024)
Group sequential designs for clinical trials when the maximum sample size is uncertain
por: Amin Yarahmadi, et al.
Publicado: (2024)
por: Amin Yarahmadi, et al.
Publicado: (2024)
Sequential Event Rate Monitoring
por: Dong‐Yun Kim, et al.
Publicado: (2026)
por: Dong‐Yun Kim, et al.
Publicado: (2026)
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
por: Yu Du, et al.
Publicado: (2024)
por: Yu Du, et al.
Publicado: (2024)
Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
por: Xiaosong Shi, et al.
Publicado: (2024)
por: Xiaosong Shi, et al.
Publicado: (2024)
Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
por: Yunfei Wang
Publicado: (2024)
por: Yunfei Wang
Publicado: (2024)
A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
por: Tianyu Zhan
Publicado: (2024)
por: Tianyu Zhan
Publicado: (2024)
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
por: Johannes Krisam, et al.
Publicado: (2024)
por: Johannes Krisam, et al.
Publicado: (2024)
Fractional accumulative calibration‐free odds (f‐aCFO) design for delayed toxicity in phase I clinical trials
por: Jialu Fang, et al.
Publicado: (2024)
por: Jialu Fang, et al.
Publicado: (2024)
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation
por: Ariel Alonso Abad, et al.
Publicado: (2024)
por: Ariel Alonso Abad, et al.
Publicado: (2024)
Are the tests overpowered or underpowered? A unified solution to correctly specify type I errors in design of clinical trials for two sample proportions
por: Peiran Liu, et al.
Publicado: (2024)
por: Peiran Liu, et al.
Publicado: (2024)
Modeling intra‐individual inter‐trial EEG response variability in autism
por: Mingfei Dong, et al.
Publicado: (2024)
por: Mingfei Dong, et al.
Publicado: (2024)
A Corrected Score Approach for Proportional Hazards Model With Error‐Contaminated Covariates Subject to Detection Limits
por: Xiao Song, et al.
Publicado: (2025)
por: Xiao Song, et al.
Publicado: (2025)
A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
por: Samuel K Sarkodie, et al.
Publicado: (2024)
por: Samuel K Sarkodie, et al.
Publicado: (2024)
Determining sample size in a personalized randomized controlled (PRACTical) trial
por: Rebecca M. Turner, et al.
Publicado: (2024)
por: Rebecca M. Turner, et al.
Publicado: (2024)
Utilizing local likelihood in regression discontinuity design: Investigating the impact of antiretroviral therapy eligibility on retention in clinical HIV care in South Africa
por: Jaehyun Seo, et al.
Publicado: (2024)
por: Jaehyun Seo, et al.
Publicado: (2024)
Beyond the two‐trials rule
por: Leonhard Held
Publicado: (2024)
por: Leonhard Held
Publicado: (2024)
Flexible Bayesian Inference for Identifying Significantly Correlated Multiple Pathway Sets
por: PhilGeun Jin, et al.
Publicado: (2026)
por: PhilGeun Jin, et al.
Publicado: (2026)
Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?
por: Matthew Dodd, et al.
Publicado: (2024)
por: Matthew Dodd, et al.
Publicado: (2024)
Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
por: Carly Lupton Brantner, et al.
Publicado: (2024)
por: Carly Lupton Brantner, et al.
Publicado: (2024)
A sequential, multiple assignment, randomized trial design with a tailoring function
por: Holly Hartman, et al.
Publicado: (2024)
por: Holly Hartman, et al.
Publicado: (2024)
Confidence intervals for odds ratio from multistage randomized phase II trials
por: Shiwei Cao, et al.
Publicado: (2024)
por: Shiwei Cao, et al.
Publicado: (2024)
Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
por: Dustin J. Rabideau, et al.
Publicado: (2024)
por: Dustin J. Rabideau, et al.
Publicado: (2024)
Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
por: Thomas Burnett, et al.
Publicado: (2024)
por: Thomas Burnett, et al.
Publicado: (2024)
Bayesian Calibration of Stochastic Agent Based Model via Random Forest
por: Connor Robertson, et al.
Publicado: (2025)
por: Connor Robertson, et al.
Publicado: (2025)
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
por: Stephen Schüürhuis, et al.
Publicado: (2024)
por: Stephen Schüürhuis, et al.
Publicado: (2024)
Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
por: Peng Yang, et al.
Publicado: (2024)
por: Peng Yang, et al.
Publicado: (2024)
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
por: Jonathan C. Moyer, et al.
Publicado: (2024)
por: Jonathan C. Moyer, et al.
Publicado: (2024)
Frequency Band Analysis of Multiple Stationary Time Series
por: Connor K. Brubaker, et al.
Publicado: (2026)
por: Connor K. Brubaker, et al.
Publicado: (2026)
Extended Joinpoint Regression Methodology for Complex Survey Data
por: Benmei Liu, et al.
Publicado: (2026)
por: Benmei Liu, et al.
Publicado: (2026)
A comparison of hyperparameter tuning procedures for clinical prediction models: A simulation study
por: Zoë S. Dunias, et al.
Publicado: (2024)
por: Zoë S. Dunias, et al.
Publicado: (2024)
Permutation Tests Based on the Copula‐Graphic Estimator and Their Use for Survival Tree Construction
por: Pauline Baur, et al.
Publicado: (2026)
por: Pauline Baur, et al.
Publicado: (2026)
Ejemplares similares
-
Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
por: Wenhao Cao, et al.
Publicado: (2024) -
Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
por: Matthias Kormaksson, et al.
Publicado: (2024) -
Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
por: Luana Boumendil, et al.
Publicado: (2024) -
Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
por: Edward L. Korn, et al.
Publicado: (2024) -
Assurance methods for designing a clinical trial with a delayed treatment effect
por: James A. Salsbury, et al.
Publicado: (2024)